tiprankstipranks
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP

Crispr Therapeutics AG (CRSP) Ownership - Who Owns Crispr Therapeutics AG?

7,202 Followers

Crispr Therapeutics AG (CRSP) Ownership Overview

22.50%16.95%59.22%1.33%
22.50% Insiders
59.22% Other Institutional Investors
1.33% Public Companies and Individual Investors
The ownership structure of Crispr Therapeutics AG (CRSP) stock is a mix of institutional, retail and individual investors. Approximately 76.17% of the company’s stock is owned by Institutional Investors, 22.50% is owned by Insiders and 1.33% is owned by Public Companies and Individual Investors.
The ownership structure of Crispr Therapeutics AG (CRSP) stock is a mix of institutional, retail and individual investors. Approximately 76.17% of the company’s stock is owned by Institutional Investors, 22.50% is owned by Insiders and 1.33% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 21, 2024
James R. Kasinger
Gc & Secretary
Sold$152409

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$208270
Dec 31, 2023Bought$327147
Dec 31, 2023Sold$3132065
Dec 31, 2023Bought$534360110

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,536,104.00Institution10.14%716,947,374.96
7,895,702.00Institution9.38%663,160,010.98
3,550,544.00Institution4.22%298,210,190.56
1,448,810.00Institution1.72%121,685,551.90
1,278,595.00Institution1.52%107,389,194.05
1,194,000.00Institution1.42%100,284,060.00
1,128,798.00Institution1.34%94,807,744.02
1,122,362.00Institution1.33%94,267,184.38
992,764.00Institution1.18%83,382,248.36
902,543.00Institution1.07%75,804,586.57

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,550,544.00Institution4.22%298,210,190.56
1,194,000.00Institution1.42%100,284,060.00
1,122,362.00Institution1.33%94,267,184.38
992,764.00Institution1.18%83,382,248.36
902,543.00Institution1.07%75,804,586.57
798,191.00Institution0.95%67,040,062.09
773,387.00Institution0.92%64,956,774.13
509,546.00Institution0.61%42,796,768.54
503,000.00Institution0.60%42,246,970.00
351,358.00Institution0.42%29,510,558.42

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
6,061,816.00Institution7.20%509,131,925.84
1,833,886.00Institution2.18%154,028,085.14
1,256,144.00Institution1.49%108,267,051.36
1,177,352.00Institution1.40%74,114,308.00
575,599.00Institution0.68%48,344,560.01
373,424.00Institution0.44%32,185,414.56
225,010.00Institution0.27%19,393,611.90
217,120.00Institution0.26%18,713,572.80
255,975.00Institution0.30%16,113,626.00
85,891.00Institution0.10%7,213,985.09

FAQ

Who Owns Crispr Therapeutics AG (CRSP)?
According to the latest TipRanks data, approximately 59.22% of the company's stock is held by institutional investors, 22.50% is held by insiders, and 1.33% is held by retail investors.
    What percentage of Crispr Therapeutics AG (CRSP) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 59.22% of Crispr Therapeutics AG (CRSP) stock is held by institutional investors.
      What percentage of Crispr Therapeutics AG (CRSP) stock is held by retail investors?
      According to the latest TipRanks data, approximately 1.33% of Crispr Therapeutics AG (CRSP) stock is held by retail investors.
        Who owns the most shares of Crispr Therapeutics AG (CRSP)?
        Cathie Wood owns the most shares of Crispr Therapeutics AG (CRSP).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis